... Imatinib mesylate (Gleevec and Imkeldi) — These TKIs are approved to treat CML and are often the first-line therapy for people who are newly diagnosed with the condition. ...
... Imatinib mesylate (Gleevec and Imkeldi) — These TKIs are approved to treat CML and are often the first-line therapy for people who are newly diagnosed with the condition. ...